Pancreatic Cancer Therapy Rates Diverge Sharply in US, Dutch Data Megan Brooks

https://www.medscape.com/viewarticle/pancreatic-cancer-therapy-rates-diverge-sharply-us-dutch-2026a10011iq?ecd=WNL_trdalrt_pos1_ous_261009_etid8776881&uac=148436CN&impID=8776881 Two large real-world studies of patients with metastatic pancreatic cancer — one from Netherlands and one from the US — paint strikingly different pictures of systemic therapy use. A nationwide Dutch study reported that nearly three quarters of patients with metastatic pancreatic cancer did not receive systemic therapy, whereas a contemporary US cohort study found that only one third did not receive treatment.